Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.06.17	Allergan to Present at the Goldman Sachs Global Healthcare Conference (PR Newswire)
02.06.17	State Sues Big Pharma For Opioid Carnage (RTTNews)
31.05.17	Allergan to Present Data from its Anti-Infectives Portfolio at ASM Microbe 2017 in New Orleans (PR Newswire)
30.05.17	Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Neurocrine Biosciences (PR Newswire)
24.05.17	Aegon Appoints Global Head of Government and Policy Affairs (PR Newswire)
24.05.17	Aegon Appoints Global Head of Government and Policy Affairs (PR Newswire)
24.05.17	Allergan Announces Early Tender Results and Upsizing of Tender Offers by Certain Subsidiaries (PR Newswire)
24.05.17	Molecular Partners wägt offenbar zwischen Partner und Kapitalerhöhung ab (AWP) Das Biotechunternehmen Molecular Partners wägt derzeit offenbar zwischen den Optionen Partner-Suche oder Kapitalerhöhung ab.» mehr
23.05.17	Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt (PR Newswire)
23.05.17	Allergan Announces Commencement of Proposed Public Offering of Senior Notes to Refinance Existing Debt (PR Newswire)
22.05.17	Aegon to Divest Majority of US Run-Off Businesses (PR Newswire)
22.05.17	Aegon to Divest Majority of US Run-Off Businesses (PR Newswire)
22.05.17	Aegon to Divest Majority of US Run-Off Businesses (PR Newswire)
19.05.17	Annual Meeting of Shareholders Adopts All Resolutions (PR Newswire)
19.05.17	Annual Meeting of Shareholders Adopts All Resolutions (PR Newswire)
16.05.17	Allergan's Eyepowerment™ Campaign Releases Survey Revealing the Importance of Eye Language and the Crucial Role it Plays in Our Communications (PR Newswire)
16.05.17	Carl Icahn Adds New Stake In Conduent, Exits Allergan And Nuance Communications (RTTNews)
15.05.17	Allergan to Present at the Bernstein Strategic Decisions Conference (PR Newswire)
11.05.17	Aegon Reports Strong Increase in Net Income in 1Q 2017 (PR Newswire)
11.05.17	Aegon Reports Strong Increase in Net Income in 1Q 2017 (PR Newswire)
10.05.17	Allergan Announces Tender Offers by Certain Subsidiaries (PR Newswire)
09.05.17	MÄRKTE USA/S&P-500 und Nasdaq markieren neue Rekordhochs (Dow Jones)
09.05.17	Wall Street mit moderatem Plus (AWP)
09.05.17	MÄRKTE USA/Wall Street leicht im Plus erwartet (Dow Jones)
09.05.17	Allergan Raises 2017 Guidance To Reflect Contribution From ZELTIQ - Quick Facts (RTTNews)
09.05.17	EARNINGS SUMMARY: Details of Allergan Inc. Q1 Earnings Report (RTTNews)
09.05.17	MARKT USA/Wall Street leicht im Plus erwartet (Dow Jones)
09.05.17	Allergan Reports Solid Start to 2017 with 5% Increase in First Quarter GAAP Net Revenues to $3.6 Billion (PR Newswire)
05.05.17	Allergan Announces Second Quarter 2017 Cash Dividend of $0.70 Per Ordinary Share (PR Newswire)
04.05.17	Allergan to Present at the Bank of America Merrill Lynch Healthcare Conference (PR Newswire)
04.05.17	Allergan to Present New Data at the 2017 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting in San Diego (PR Newswire)
02.05.17	Allergan Solidifies Strong Footprint at ARVO 2017 with Several Data Presentations (PR Newswire)
01.05.17	Allergan to Present New and Updated Linzess®, Viberzi®, Relamorelin, Linaclotide Delayed Release, and Cenicriviroc Data at Digestive Disease Week® 2017 (PR Newswire)
28.04.17	Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition (PR Newswire)
27.04.17	Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Rigel Pharma (PR Newswire)
25.04.17	Allergan Announces Marketing Authorization For TrueTear - Quick Facts (RTTNews)
25.04.17	Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven to Temporarily Increase Tear Production (PR Newswire)
20.04.17	Allergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical Dystonia and Alzheimer's Disease at the American Academy of Neurology Meeting in Boston (PR Newswire)
20.04.17	Allergan Partners with TARGET PharmaSolutions to Advance NASH Research (PR Newswire)
18.04.17	Allergan, Novartis In Clinical Trial Deal To Treat NASH - Quick Facts (RTTNews)
18.04.17	Novartis Collaborates With Allergan On NASH - Quick Facts (RTTNews)
18.04.17	Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration (PR Newswire)
11.04.17	Allergan Launches Frames of Mind, Encouraging People Living with Migraine to Share Common Experiences Through Art (PR Newswire)
10.04.17	Allergan Receives 2017 ENERGY STAR® Partner of the Year - Sustained Excellence Award from U.S. Environmental Protection Agency (PR Newswire)
07.04.17	Allergan Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campaign - Toilet Talk (PR Newswire)
07.04.17	Aegon Publishes Agenda for 2017 Annual General Meeting (PR Newswire)
07.04.17	Aegon Publishes Agenda for 2017 Annual General Meeting (PR Newswire)
06.04.17	Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy (PR Newswire)
06.04.17	Rivel Releases Unprecedented International Study on Guidance Showing Deep Concern over Consensus Earnings and Short-term Volatility (PR Newswire)
06.04.17	Allergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09.02.20		Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal
04.10.19		Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an
04.08.19		Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor
05.05.19		Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse
19.02.18		Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten
22.12.17		Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

09.02.20

Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal

04.10.19

Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an

04.08.19

Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor

05.05.19

Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse

19.02.18

Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten

22.12.17

Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	262.10	3.39 %	K V
Lonza Grp	584.80	2.38 %	K V
Logitech Intl	66.76	1.71 %	K V
Part Grp Hldg	1’114.00	1.41 %	K V
Swisscom	544.00	0.74 %	K V
ABB	45.07	0.04 %	K V
Novartis	90.91	-0.22 %	K V
Zurich Insur Gr	581.00	-0.34 %	K V
Roche Hldg G	257.60	-0.88 %	K V
Kuehne+Nagel Int	177.85	-3.24 %	K V

Allergan Aktie VALOR 28551749 / ISIN IE00BY9D5467

Nachrichten zu Allergan plc

Aktien Top/Flop

Allergan Peer Group Nachrichten

Meistgelesene Nachrichten